DAXX/ATRX, MEN1, and mTOR pathway genes are frequently altered in pancreatic neuroendocrine tumors - Test2 - elhamkhani - TriplyDB

DAXX/ATRX, MEN1, and mTOR pathway genes are frequently altered in pancreatic neuroendocrine tumors

DAXX/ATRX, MEN1, and mTOR pathway genes are frequently altered in pancreatic neuroendocrine tumors

http://www.wikidata.org/entity/Q28303693

about

The spectrum of SWI/SNF mutations, ubiquitous in human cancers Cancer genome landscapes ATRX dysfunction induces replication defects in primary mouse cells NCG 4.0: the network of cancer genes in the era of massive mutational screenings of cancer genomes A decade of exploring the cancer epigenome - biological and translational implications Network of Cancer Genes (NCG 3.0): integration and analysis of genetic and network properties of cancer genes Recent progress in pancreatic cancer Integrated genomic analyses identify ARID1A and ARID1B alterations in the childhood cancer neuroblastoma The pivotal role of mammalian target of rapamycin inhibition in the treatment of patients with neuroendocrine tumors Surgical and molecular pathology of pancreatic neoplasms Sirolimus and Everolimus Pathway: Reviewing Candidate Genes Influencing Their Intracellular Effects The mTOR pathway in obesity driven gastrointestinal cancers: Potential targets and clinical trials Medical treatment for gastro-entero-pancreatic neuroendocrine tumours Notch Signaling in Neuroendocrine Tumors Epigenetic modulators, modifiers and mediators in cancer aetiology and progression The PI3K/Akt Pathway in Tumors of Endocrine Tissues Neuroendocrine differentiation: The mysterious fellow of colorectal cancer Application and Dosimetric Requirements for Gallium-68-labeled Somatostatin Analogues in Targeted Radionuclide Therapy for Gastroenteropancreatic Neuroendocrine Tumors Telomere biology: Rationale for diagnostics and therapeutics in cancer Human β-cell proliferation and intracellular signaling: part 3 Linking epithelial-to-mesenchymal-transition and epigenetic modifications Mutational signatures: the patterns of somatic mutations hidden in cancer genomes PI3K-AKT-mTOR-signaling and beyond: the complex network in gastroenteropancreatic neuroendocrine neoplasms Genetic basis of pancreas cancer development and progression: insights from whole-exome and whole-genome sequencing How many molecular subtypes? Implications of the unique tumor principle in personalized medicine Myeloid malignancies: mutations, models and management Every amino acid matters: essential contributions of histone variants to mammalian development and disease Human correlates of provocative questions in pancreatic pathology Combinatorial readout of histone H3 modifications specifies localization of ATRX to heterochromatin BRAFV600E Mutations in High-Grade Colorectal Neuroendocrine Tumors May Predict Responsiveness to BRAF-MEK Combination Therapy.A Cul4 E3 ubiquitin ligase regulates histone hand-off during nucleosome assembly.The Role of ATRX in the Alternative Lengthening of Telomeres (ALT) Phenotype Management of neuroendocrine carcinomas of the pancreas (WHO G3): A tailored approach between proliferation and morphology Summary of emerging personalized medicine in neuroendocrine tumors: are we on track?Loss of ATRX Suppresses Resolution of Telomere Cohesion to Control Recombination in ALT Cancer Cells Mutations in CIC and FUBP1 contribute to human oligodendroglioma Exome sequencing identifies frequent mutation of ARID1A in molecular subtypes of gastric cancer Neuroendocrine pancreatic tumors: guidelines for management and update Dualistic function of Daxx at centromeric and pericentromeric heterochromatin in normal and stress conditions Inactivating CUX1 mutations promote tumorigenesis

P2860

Q21090801-A9EB3DD4-7A55-46A7-9B40-709529B72A6F Q22242276-8921C011-7911-43D7-9847-4246CE652772 Q24339453-062686AA-48EA-4246-8576-6E8395BBB9E8 Q24596715-AC2705AF-C594-4F1C-B027-0260E80DB97F Q24614467-9AB9A0F8-F0FE-41EA-950C-1220DF7CBD3E Q24619351-0F0E778D-D921-4AA5-8CC1-77F791E1ADE6 Q24626346-DC8A6D44-1833-4D26-A68F-A2A6194BEBB6 Q24630017-3E6209CC-ACF0-4108-AAE8-1619B2F97A3D Q26740374-C03BDCBD-63F6-4C5A-9AB4-79379116A886 Q26748615-83BED46D-9F51-4B12-AD5C-EA07F4F8D443 Q26749011-A7982654-6BF9-46FE-A362-C8723D6D8ABA Q26751155-325461D6-EB1B-46CC-86C3-527D80FE07C6 Q26751659-D6D3A06F-90FA-4037-BBAD-6577B5DC17C5 Q26752380-43B125FB-3DFF-4BB5-B905-864291F5AC7D Q26766149-75B2A4AA-9BAC-4013-98CA-7726A645C4E7 Q26770404-81120DE7-139A-4C36-9A04-A9D0EF4D53D0 Q26778012-B663C2CE-F83E-471A-AB5A-1AD35F192150 Q26783272-B685DA0B-ADBA-4055-B34E-BC972724518C Q26796323-F7463E7D-DA6A-48DE-98F5-0ACA080798A4 Q26821954-B7090544-12DA-4C28-8973-124A7FFBC41E Q26824575-41D84A9E-E6D0-4F33-8761-ADF1BC9872B8 Q26850125-92A2A228-218F-41DD-BEF6-73C0ACDECBD7 Q26862544-9B174777-C3D4-44C9-B7B6-1B35A01B2927 Q26991615-7A8B4A43-B1CF-4CDC-A578-1EB70D50B613 Q26992045-665CB468-9019-4945-823B-11716A3B6135 Q27000577-A2D628D4-6953-4109-B31F-CA59F6B7EA90 Q27008522-335066A2-D9C2-4A8A-AA28-CD05E5749739 Q27023576-8C676916-BEA4-46C0-8C75-8271A03FBFDF Q27670415-B2ED535D-9C28-4637-B35E-DC74BB9EFBB2 Q27853371-82CA5325-289E-48DB-8CB2-00939C16D5D8 Q27936513-BCCA2536-C7A9-484A-97FE-AF291094F592 Q28071562-A06BFB27-D33F-4257-A77A-2E8175B9CA87 Q28078501-66B66C9C-CEEE-4157-834A-B73763D2FBFE Q28078610-AECC8EEE-CBBE-4B10-B832-BDF785FF0F31 Q28115086-F259F86F-B3BD-40EC-A7D5-D307A17EBF91 Q28244895-967B3DB6-E9A0-4557-AE18-041B18F59D5F Q28251814-C65CB36B-9C51-47E4-873E-AD553203A51E Q28256132-FB301295-8D67-451F-B1A6-422DB122399C Q28266294-EE6A9BC3-7F69-4CF5-8224-38DEB371FB16 Q28303563-E14328F6-E291-4A11-A7EC-26E7B836E443

P2860

DAXX/ATRX, MEN1, and mTOR pathway genes are frequently altered in pancreatic neuroendocrine tumors

http://www.wikidata.org/entity/Q28303693

description

2011 nî lūn-bûn

@nan

2011 թուականի Մարտին հրատարակուած գիտական յօդուած

@hyw

2011 թվականի մարտին հրատարակված գիտական հոդված

@hy

2011年の論文

@ja

2011年論文

@yue

2011年論文

@zh-hant

2011年論文

@zh-hk

2011年論文

@zh-mo

2011年論文

@zh-tw

2011年论文

@wuu

name

DAXX/ATRX, MEN1, and mTOR path ...... ncreatic neuroendocrine tumors

@ast

DAXX/ATRX, MEN1, and mTOR path ...... ncreatic neuroendocrine tumors

@en

DAXX/ATRX, MEN1, and mTOR path ...... ncreatic neuroendocrine tumors

@nl

type

label

DAXX/ATRX, MEN1, and mTOR path ...... ncreatic neuroendocrine tumors

@ast

DAXX/ATRX, MEN1, and mTOR path ...... ncreatic neuroendocrine tumors

@en

DAXX/ATRX, MEN1, and mTOR path ...... ncreatic neuroendocrine tumors

@nl

prefLabel

DAXX/ATRX, MEN1, and mTOR path ...... ncreatic neuroendocrine tumors

@ast

DAXX/ATRX, MEN1, and mTOR path ...... ncreatic neuroendocrine tumors

@en

DAXX/ATRX, MEN1, and mTOR path ...... ncreatic neuroendocrine tumors

@nl

P1433

Q28303693-FE98BB87-E7C7-4E9A-BD30-E490D6CE6F2C

P1476

Q28303693-649F2AB9-C7C6-4447-A489-562DD8B527E8

P2093

Q28303693-01186F20-055B-4ED1-853A-F9A35CC63A86

Q28303693-0771E171-C5A1-4927-A164-0298FB94F191

Q28303693-12276221-23AB-4760-BABB-9784F6197AC2

Q28303693-3857698C-9414-41A7-B13F-3C1732FC3A21

Q28303693-562D4310-6BCB-4450-AA1D-DA44C4F99C18

Q28303693-898D6C15-5DAA-4F9C-B407-813CC7DEF6A6

Q28303693-CB81F936-2FD3-4078-8C27-5F82BAA2C4BA

Q28303693-D240D25D-888D-450B-9F11-68696784D53B

Q28303693-D9DB2863-3038-4516-91C5-7FFE58DDD495

Q28303693-DAEA326E-9402-4FCC-AFF4-49EF7AB86CF0

P2860

Q28303693-207FBF80-CEB2-4233-B70D-DF29875CB7C7

Q28303693-2948E26A-8F8F-4E2F-A167-A110A2B9176C

Q28303693-29E21D06-4513-43AF-8846-CA87AB132A47

Q28303693-2D2A65C9-D691-4AF1-A9D8-5DE39215CD99

Q28303693-3AB701D9-DEE7-403F-B319-F8E8DF19F893

Q28303693-41451E86-1E93-48BE-A5B1-1CCEC55DF757

Q28303693-49568375-96BB-4E82-9727-696A99D2EAFA

Q28303693-50FDE734-501D-4843-8DAE-B35200E7BEDE

Q28303693-54C830D0-0833-4D9D-811D-EBE8F3F609F5

Q28303693-57660E7C-CF2B-4F22-B832-5D5763D8F8B0

P304

Q28303693-64790B4D-82F3-44B9-B6A9-9A18E75D91F0

P31

Q28303693-F352BBE5-1507-4104-B828-0A35DDC08915

P3181

Q28303693-05C31022-06BD-47BC-AA33-7A59708F52DF

P356

Q28303693-8D289ECF-E61D-4EEB-B6AE-FAFD79E33DC3

P407

Q28303693-6A5CF3B5-06B1-4C37-9DF1-AA01D9A034A0

P433

Q28303693-9C7F3DDD-0997-46A2-9A34-E7B0BB2E1605

P478

Q28303693-D4FCBD86-5646-4327-B190-0977E09BF764

P50

Q28303693-2370989D-DB3E-4721-8177-EA06AD15EEC0

Q28303693-5D98D7BE-6D43-4953-9DFC-A6B096DB1D09

Q28303693-6284438B-47E0-4DAA-B54C-64C8CBB6E949

Q28303693-6859CC52-BD79-4639-80E1-B69E3040FFC9

Q28303693-DFB3DAD3-ED9A-4121-BD71-8EDDAA0C4CF7

P577

Q28303693-ADAAFC27-62DE-417A-A49D-774733CE4E93

P5875

Q28303693-90CBF35A-8AF7-4333-9099-5E2573204A91

P698

Q28303693-EAEE89E6-9BB7-4BFB-95A2-1C05CA2A2AF6

P932

Q28303693-42FCE5D7-D33D-40AE-8CAD-283603DF3CDD

P3181

P356

SCIENCE.1200609

P1433

P1476

DAXX/ATRX, MEN1, and mTOR path ...... ncreatic neuroendocrine tumors

@en

P2093

Anirban Maitra

http://www.w3.org/2001/XMLSchema#string

Barish H Edil

http://www.w3.org/2001/XMLSchema#string

Chanjuan Shi

http://www.w3.org/2001/XMLSchema#string

Christopher L Wolfgang

http://www.w3.org/2001/XMLSchema#string

David S Klimstra

http://www.w3.org/2001/XMLSchema#string

Laura H Tang

http://www.w3.org/2001/XMLSchema#string

Michael A Choti

http://www.w3.org/2001/XMLSchema#string

Nickolas Papadopoulos

http://www.w3.org/2001/XMLSchema#string

Richard D Schulick

http://www.w3.org/2001/XMLSchema#string

Roeland F de Wilde

http://www.w3.org/2001/XMLSchema#string

P2860

Menin interacts with the AP1 transcription factor JunD and represses JunD-activated transcription

Daxx is an H3.3-specific histone chaperone and cooperates with ATRX in replication-independent chromatin assembly at telomeres

Leukemia proto-oncoprotein MLL forms a SET1-like histone methyltransferase complex with menin to regulate Hox gene expression

Menin associates with a trithorax family histone methyltransferase complex and with the hoxc8 locus

The death-associated protein DAXX is a novel histone chaperone involved in the replication-independent deposition of H3.3

Core signaling pathways in human pancreatic cancers revealed by global genomic analyses

ATRX interacts with H3.3 in maintaining telomere structural integrity in pluripotent embryonic stem cells

Defining the role of mTOR in cancer

Distinct factors control histone variant H3.3 localization at specific genomic regions

Ras, PI(3)K and mTOR signalling controls tumour cell growth

P304

1199-203

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P3181

652309

http://www.w3.org/2001/XMLSchema#string

P356

10.1126/SCIENCE.1200609

http://www.w3.org/2001/XMLSchema#string

P407

P433

6021

http://www.w3.org/2001/XMLSchema#string

P478

331

http://www.w3.org/2001/XMLSchema#string

P50

Ralph H. Hruban

Kenneth W Kinzler

Luis Alberto Diaz Jr

Victor Velculescu

Bert Vogelstein

P577

2011-03-04T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

49771920

http://www.w3.org/2001/XMLSchema#string

P698

21252315

http://www.w3.org/2001/XMLSchema#string

P932

3144496

http://www.w3.org/2001/XMLSchema#string